Article
17 Oct 2025
Conception & Inventorship Under Pharmaceutical Patent Law: Lessons And Best Practices
CONTRIBUTING SINCE MAY 2024
Upadhye Tang
UT is your “go-to” US law firm for pharma/life science IP & FDA law. We integrate patent strategy/litigation with FDA regulatory standards to solve your business needs. Our team is focused, experienced, and flexible. This provides efficiency and cost savings. We wrote the book on pharma IP and FDA law.
POPULAR TOPICS
Intellectual Property
Food, Drugs, Healthcare, Life Sciences
Corporate/Commercial Law
Upadhye Tang are most popular:
- within Corporate/Commercial Law topic(s)
- with Inhouse Counsel
- with readers working within the Technology and Property industries
DETAILS
COMPANY CONTENT
Article
01 Aug 2025
Preserving Attorney-Client Privilege In Mergers And Acquisitions: Navigating The Common Interest Doctrine
Article
04 Jul 2025
The Perils Of Broad Patent Claims: From Issuance To Invalidity
Article
27 Jun 2025
Your Rights If FDA Agreed To Your Proposed Q1/Q2 ANDA Formulation But Sends A Refuse To Receive (RTR) Instead?
Article
19 Mar 2025
Patent & Regulatory Legal Issues Related To Fertilizers, Fungicides, Pesticides, & Bulk Chemicals
Article
17 Mar 2025
Intellectual Property Issues Related To Artificial Intelligence: A Deeper Dive Into Patent, Copyright, & Trade Secrets Challenges
Article
10 Jan 2025
Pending 2025 FDA Legislation On Pharmaceutical Development & Marketing: A Comprehensive Industry Impact Analysis
Article
19 Nov 2024
Infringing Your Own Intellectual Property: Understanding The Paradox
Article
17 Oct 2024
Proving Patent Infringement – Double Counting Pharmaceutical Ingredients When One Element Satisfies Two Claim Limitations
Article
28 Aug 2024
The Right To Repair Versus Reconstruction Under U.S. Patent Law: An In-Depth Analysis
Article
25 Jul 2024
Does Drug Quality Matter? Do Lives Matter?
Article
24 Jul 2024
Data Falsification/Data Integrity - You Can Run But You Cannot Hide
Article
24 Jul 2024
Inducement To Infringe Is Not A Strict Liability Test
Article
24 Jul 2024
The Culture Of CGMP Compliance - More Falsified Data
Article
18 Jul 2024
On The Use Of Generative AI In Patent Litigation
Article
17 Jun 2024
Navigating Administrative Law: Understanding The Basics Of Challenging Federal Agency Decisions
Article
16 May 2024
Ophthalmic, Parenteral, & Otic Drug Development: Does FDA's Draft Guidance Provide A Vehicle To Avoid Patent Problems?
Article
16 May 2024
Billion Dollar Verdicts Wiped Out Due To Patent Law's Written Description
Article
16 May 2024
Five (5) & Ten (10) Year Data Exclusivity For New Drugs – When To File Generic Drug Applications
Article
16 May 2024
The Role Of Prior Art In Patent Law – Old And Admitted Prior Art